Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Rischin

Showing results (11-20 of 224) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
High-Dose Cisplatin for Head and Neck Cancer Lives OnAlesha A Thai, Danny Rischin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Merkel cell carcinoma: emerging biology, current approaches, and future directionsRichard Tothill, Vanessa Estall, Danny Rischin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 8, 2010
Comparison of self-reported smoking status and physician-recorded smoking status among patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)Mateya Trinkaus, June Corry, Danny Rischin
The New England Journal of Medicine|November 12, 2025
Adjuvant Cemiplimab in Cutaneous Squamous-Cell Carcinoma. ReplyDanny Rischin, Sandro Porceddu, Fiona Day
Cancer|March 1, 2014
What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Damien Urban, June Corry, Danny Rischin
The Lancet. Oncology|March 6, 2010
Optimising the therapeutic ratio in head and neck cancerJune Corry, Lester J Peters, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Impact of center size and experience on outcomes in head and neck cancerJune Corry, Lester J Peters, Danny Rischin
Current Oncology (Toronto, Ont.)|August 27, 2025
Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell CarcinomaAnnette M Lim, Sandro Porceddu, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumorsFiona L Day, Jonathan Karnon, Danny Rischin
Seminars in Cancer Biology|January 23, 2018
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatmentsBenjamin Solomon, Richard J Young, Danny Rischin
Pageof 23

Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
High-Dose Cisplatin for Head and Neck Cancer Lives OnAlesha A Thai, Danny Rischin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Merkel cell carcinoma: emerging biology, current approaches, and future directionsRichard Tothill, Vanessa Estall, Danny Rischin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 8, 2010
Comparison of self-reported smoking status and physician-recorded smoking status among patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)Mateya Trinkaus, June Corry, Danny Rischin
The New England Journal of Medicine|November 12, 2025
Adjuvant Cemiplimab in Cutaneous Squamous-Cell Carcinoma. ReplyDanny Rischin, Sandro Porceddu, Fiona Day
Cancer|March 1, 2014
What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Damien Urban, June Corry, Danny Rischin
The Lancet. Oncology|March 6, 2010
Optimising the therapeutic ratio in head and neck cancerJune Corry, Lester J Peters, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Impact of center size and experience on outcomes in head and neck cancerJune Corry, Lester J Peters, Danny Rischin
Current Oncology (Toronto, Ont.)|August 27, 2025
Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell CarcinomaAnnette M Lim, Sandro Porceddu, Danny Rischin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2011
Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumorsFiona L Day, Jonathan Karnon, Danny Rischin
Seminars in Cancer Biology|January 23, 2018
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatmentsBenjamin Solomon, Richard J Young, Danny Rischin
Pageof 23